General Information of the Protein
Protein ID
PT03476
Protein Name
Polymerase basic protein 2
Secondarily
Protein Name
RNA-directed RNA polymerase subunit P3
Gene Name
PB2
Sequence
MERIKELRNLMSQSRTREILTKTTVDHMAIIKKYTSGRQEKNPALRMKWMMAMKYPITADKRITEMIPERNEQGQTLWSKMNDAGSDRVMVSPLAVTWWNRNGPITNTVHYPKIYKTYFERVERLKHGTFGPVHFRNQVKIRRRVDINPGHADLSAKEAQDVIMEVVFPNEVGARILTSESQLTITKEKKEELQDCKISPLMVAYMLERELVRKTRFLPVAGGTSSVYIEVLHLTQGTCWEQMYTPGGEVRNDDVDQSLIIAARNIVRRAAVSADPLASLLEMCHSTQIGGIRMVDILRQNPTEEQAVDICKAAMGLRISSSFSFGGFTFKRTSGSSVKREEEVLTGNLQTLKIRVHEGYEEFTMVGRRATAILRKATRRLIQLIVSGRDEQSIAEAIIVAMVFSQEDCMIKAVRGDLNFVNRANQRLNPMHQLLRHFQKDAKVLFQNWGVEPIDNVMGMIGILPDMTPSIEMSMRGVRISKMGVDEYSSTERVVVSIDRFLRIRDQRGNVLLSPEEVSETQGTEKLTITYSSSMMWEINGPESVLVNTYQWIIRNWETVKIQWSQNPTMLYNKMEFEPFQSLVPKAIRGQYSGFVRTLFQQMRDVLGTFDTAQIIKLLPFAAAPPKQSRMQFSSFTVNVRGSGMRILVRGNSPVFNYNKATKRLTVLGKDAGTLTEDPDEGTAGVESAVLRGFLILGKEDKRYGPALSINELSNLAKGEKANVLIGQGDVVLVMKRKRDSSILTDSQTATKRIRMAIN
    Show/Hide
Organism
Influenza A virus (strain A/Puerto Rico/8/1934 H1N1)
Protein Classification
Unclassified protein
Function
Plays an essential role in transcription initiation and cap-stealing mechanism, in which cellular capped pre-mRNAs are used to generate primers for viral transcription. Recognizes and binds the 7-methylguanosine-containing cap of the target pre-RNA which is subsequently cleaved after 10-13 nucleotides by the viral protein PA. Plays a role in the initiation of the viral genome replication and modulates the activity of the ribonucleoprotein (RNP) complex. In addition, participates in the inhibition of type I interferon induction through interaction with and inhibition of the host mitochondrial antiviral signaling protein MAVS.
    Show/Hide
Uniprot ID
Primary ID:
P03428

Secondarily ID:
A4GXH0
Q20N28
Q8JUU8
    Show/Hide
Subcellular Location
Virion
Host nucleus
Host mitochondrion
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000031 , MDCK
Compound ID Compound Name Compound Formula
CP0468624
(2S,3S)-3-[[2-(5-fluoro-2H-pyrazolo[3,4-b]pyridin-3-yl)thieno[2,3-d]pyrimidin-4-yl]amino]bicyclo[2.2.2]octane-2-carboxylic acid
   Show/Hide
C21H19FN6O2S
 1
1
EC50 = 0.06 nM
   TI
   LI
   LO
   TS
CP0429621
(2S,3S)-3-[[2-(5-fluoro-1H-pyrrolo[2,3-b]pyridin-3-yl)thieno[2,3-d]pyrimidin-4-yl]amino]bicyclo[2.2.2]octane-2-carboxylic acid
   Show/Hide
C22H20FN5O2S
 1
1
EC50 = 0.2 nM
   TI
   LI
   LO
   TS
CP0482034
(2S,3S)-3-[[2-(5-fluoro-2H-pyrazolo[3,4-b]pyridin-3-yl)-6,7-dihydrothieno[3,2-d]pyrimidin-4-yl]amino]bicyclo[2.2.2]octane-2-carboxylic acid
   Show/Hide
C21H21FN6O2S
 1
1
EC50 = 0.2 nM
   TI
   LI
   LO
   TS
CP0567305
(2S,3S)-3-[[2-(5-fluoro-1H-pyrrolo[2,3-b]pyridin-3-yl)-6,7-dihydrothieno[3,2-d]pyrimidin-4-yl]amino]bicyclo[2.2.2]octane-2-carboxylic acid
   Show/Hide
C22H22FN5O2S
 1
1
EC50 = 0.4 nM
   TI
   LI
   LO
   TS
CP0458025
(2S,3S)-3-[[2-(5-fluoro-1H-pyrrolo[2,3-b]pyridin-3-yl)thieno[3,2-d]pyrimidin-4-yl]amino]bicyclo[2.2.2]octane-2-carboxylic acid
   Show/Hide
C22H20FN5O2S
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0519460
(2S,3S)-3-[[2-(5-fluoro-2H-pyrazolo[3,4-b]pyridin-3-yl)thieno[3,2-d]pyrimidin-4-yl]amino]bicyclo[2.2.2]octane-2-carboxylic acid
   Show/Hide
C21H19FN6O2S
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0100388
(2S,3S)-3-[[5-fluoro-2-(5-fluoro-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-yl]amino]bicyclo[2.2.2]octane-2-carboxylic acid
   Show/Hide
C20H19F2N5O2
 1
1
EC50 = 0.6 nM
   TI
   LI
   LO
   TS
CP0549184
(2S,3S)-3-[[2-(5-fluoro-1H-pyrrolo[2,3-b]pyridin-3-yl)thieno[3,4-d]pyrimidin-4-yl]amino]bicyclo[2.2.2]octane-2-carboxylic acid
   Show/Hide
C22H20FN5O2S
 1
1
EC50 = 1.4 nM
   TI
   LI
   LO
   TS
CP0519459
(2S,3S)-3-[[2-(5-fluoro-1H-pyrrolo[2,3-b]pyridin-3-yl)-5,7-dihydrothieno[3,4-d]pyrimidin-4-yl]amino]bicyclo[2.2.2]octane-2-carboxylic acid
   Show/Hide
C22H22FN5O2S
 1
1
EC50 = 2.6 nM
   TI
   LI
   LO
   TS
CP0549186
(2S,3S)-3-[[2-(5-fluoro-1H-pyrrolo[2,3-b]pyridin-3-yl)-5,6-dihydrothieno[2,3-d]pyrimidin-4-yl]amino]bicyclo[2.2.2]octane-2-carboxylic acid
   Show/Hide
C22H22FN5O2S
 1
1
EC50 = 2.8 nM
   TI
   LI
   LO
   TS
CP0446068
(2S,3S)-3-[[5-(5-fluoro-1H-pyrrolo[2,3-b]pyridin-3-yl)-[1,3]thiazolo[5,4-d]pyrimidin-7-yl]amino]bicyclo[2.2.2]octane-2-carboxylic acid
   Show/Hide
C21H19FN6O2S
 1
1
EC50 = 3 nM
   TI
   LI
   LO
   TS
CP0549183
(2S,3S)-3-[[7-cyano-2-(5-fluoro-1H-pyrrolo[2,3-b]pyridin-3-yl)thieno[3,2-d]pyrimidin-4-yl]amino]bicyclo[2.2.2]octane-2-carboxylic acid
   Show/Hide
C23H19FN6O2S
 1
1
EC50 = 4 nM
   TI
   LI
   LO
   TS
CP0954106
(2S,3S)-3-((2-(5-fluoro-1H-pyrrolo[2,3-b]pyridin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)bicyclo[2.2.2]octane-2-carboxylic acid
   Show/Hide
C22H21FN6O2
 1
1
EC50 = 4.5 nM
   TI
   LI
   LO
   TS
CP0567304
(2S,3S)-3-[[2-(5-fluoro-1H-pyrrolo[2,3-b]pyridin-3-yl)furo[3,2-d]pyrimidin-4-yl]amino]bicyclo[2.2.2]octane-2-carboxylic acid
   Show/Hide
C22H20FN5O3
 1
1
EC50 = 5.3 nM
   TI
   LI
   LO
   TS
CP0557238
(2S,3S)-3-[[2-(5-fluoro-1H-pyrrolo[2,3-b]pyridin-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl]amino]bicyclo[2.2.2]octane-2-carboxylic acid
   Show/Hide
C23H24FN5O2
 1
1
EC50 = 5.5 nM
   TI
   LI
   LO
   TS
CP0554943
(2S,3S)-3-[[5-fluoro-2-(5-fluoro-1H-pyrrolo[2,3-b]pyridin-3-yl)-7-methylpyrrolo[2,3-d]pyrimidin-4-yl]amino]bicyclo[2.2.2]octane-2-carboxylic acid
   Show/Hide
C23H22F2N6O2
 1
1
EC50 = 9.6 nM
   TI
   LI
   LO
   TS
CP0482032
(2S,3S)-3-[[6-(difluoromethyl)-2-(5-fluoro-1H-pyrrolo[2,3-b]pyridin-3-yl)thieno[3,2-d]pyrimidin-4-yl]amino]bicyclo[2.2.2]octane-2-carboxylic acid
   Show/Hide
C23H20F3N5O2S
 1
1
EC50 = 10 nM
   TI
   LI
   LO
   TS
CP0549176
(2S,3S)-3-[[7-fluoro-2-(5-fluoro-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrido[3,2-d]pyrimidin-4-yl]amino]bicyclo[2.2.2]octane-2-carboxylic acid
   Show/Hide
C23H20F2N6O2
 1
1
EC50 = 10 nM
   TI
   LI
   LO
   TS
CP0446067
(2S,3S)-3-[[2-(5-fluoro-1H-pyrrolo[2,3-b]pyridin-3-yl)-7-methylpyrido[3,2-d]pyrimidin-4-yl]amino]bicyclo[2.2.2]octane-2-carboxylic acid
   Show/Hide
C24H23FN6O2
 1
1
EC50 = 11 nM
   TI
   LI
   LO
   TS
CP0554942
(2S,3S)-3-[[2-(5-fluoro-1H-pyrrolo[2,3-b]pyridin-3-yl)-5-methylquinazolin-4-yl]amino]bicyclo[2.2.2]octane-2-carboxylic acid
   Show/Hide
C25H24FN5O2
 1
1
EC50 = 11 nM
   TI
   LI
   LO
   TS
CP0458024
(2S,3S)-3-[[2-(5-fluoro-1H-pyrrolo[2,3-b]pyridin-3-yl)-5,6,7,8-tetrahydroquinazolin-4-yl]amino]bicyclo[2.2.2]octane-2-carboxylic acid
   Show/Hide
C24H26FN5O2
 1
1
EC50 = 12 nM
   TI
   LI
   LO
   TS
CP0473817
(2S,3S)-3-[2-(5-fluoro-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrrolo[2,3-d]pyrimidin-7-yl]bicyclo[2.2.2]octane-2-carboxylic acid
   Show/Hide
C22H20FN5O2
 1
1
EC50 = 12 nM
   TI
   LI
   LO
   TS
CP0468623
(2S,3S)-3-[[2-(5-fluoro-1H-pyrrolo[2,3-b]pyridin-3-yl)pteridin-4-yl]amino]bicyclo[2.2.2]octane-2-carboxylic acid
   Show/Hide
C22H20FN7O2
 1
1
EC50 = 13 nM
   TI
   LI
   LO
   TS
CP0458023
(2S,3S)-3-[[2-(5-fluoro-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrido[3,2-d]pyrimidin-4-yl]amino]bicyclo[2.2.2]octane-2-carboxylic acid
   Show/Hide
C23H21FN6O2
 1
1
EC50 = 14 nM
   TI
   LI
   LO
   TS
CP0567303
(2S,3S)-3-[[5-fluoro-2-(5-fluoro-1H-pyrrolo[2,3-b]pyridin-3-yl)quinazolin-4-yl]amino]bicyclo[2.2.2]octane-2-carboxylic acid
   Show/Hide
C24H21F2N5O2
 1
1
EC50 = 20 nM
   TI
   LI
   LO
   TS
CP0554941
(2S,3S)-3-[2-(5-fluoro-1H-pyrrolo[2,3-b]pyridin-3-yl)-6,7-dihydropyrimido[5,4-b][1,4]oxazin-8-yl]bicyclo[2.2.2]octane-2-carboxylic acid
   Show/Hide
C22H22FN5O3
 1
1
EC50 = 24 nM
   TI
   LI
   LO
   TS
CP0563552
(2S,3S)-3-[5-cyano-2-(5-fluoro-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrrolo[2,3-d]pyrimidin-7-yl]bicyclo[2.2.2]octane-2-carboxylic acid
   Show/Hide
C23H19FN6O2
 1
1
EC50 = 70 nM
   TI
   LI
   LO
   TS
CP0559670
(2S,3S)-3-[[2-(5-fluoro-1H-pyrrolo[2,3-b]pyridin-3-yl)-5,5-dioxo-6,7-dihydrothieno[3,2-d]pyrimidin-4-yl]amino]bicyclo[2.2.2]octane-2-carboxylic acid
   Show/Hide
C22H22FN5O4S
 1
1
EC50 = 110 nM
   TI
   LI
   LO
   TS
CP0446066
(2S,3S)-3-[2-(5-fluoro-1H-pyrrolo[2,3-b]pyridin-3-yl)purin-9-yl]bicyclo[2.2.2]octane-2-carboxylic acid
   Show/Hide
C21H19FN6O2
 1
1
EC50 = 190 nM
   TI
   LI
   LO
   TS
CP0519462
(2S,3S)-3-[[5-fluoro-2-(5-fluoro-1H-indol-3-yl)pyrimidin-4-yl]amino]bicyclo[2.2.2]octane-2-carboxylic acid
   Show/Hide
C21H20F2N4O2
 1
1
EC50 = 220 nM
   TI
   LI
   LO
   TS
CP0559671
(2S,3S)-3-[[5-fluoro-2-(6-fluoropyrrolo[3,2-b]pyridin-1-yl)pyrimidin-4-yl]amino]bicyclo[2.2.2]octane-2-carboxylic acid
   Show/Hide
C20H19F2N5O2
 1
1
EC50 = 230 nM
   TI
   LI
   LO
   TS
CP0559672
(2S,3S)-3-[[4-(5-fluoro-1H-pyrrolo[2,3-b]pyridin-3-yl)-5-methylquinazolin-2-yl]amino]bicyclo[2.2.2]octane-2-carboxylic acid
   Show/Hide
C25H24FN5O2
 1
1
EC50 = 450 nM
   TI
   LI
   LO
   TS
CP0482033
(2S,3S)-3-[[2-(5-fluoro-1H-pyrrolo[2,3-b]pyridin-3-yl)-6,6-dioxo-5,7-dihydrothieno[3,4-d]pyrimidin-4-yl]amino]bicyclo[2.2.2]octane-2-carboxylic acid
   Show/Hide
C22H22FN5O4S
 1
1
EC50 = 2000 nM
   TI
   LI
   LO
   TS
Clinical Information about the Protein
Target 1 ( Influenza Polymerase basic protein 2 (Influ PB2) )
Target Type Clinical trial Target
Disease 1 Target-related Disease  1
1 Influenza A virus infection [ICD-11: 1E30]
Clinical Trial Drug(s) 1 Clinical Trial Drug  1
1 VX-787 Phase 3
Influenza A virus infection